About this opportunity
Scorpion Therapeutics lists this Director, Integrative Sciences opportunity in collegeville, Pennsylvania. Review the employer’s description below for duties, qualifications and application requirements.
Job description
Director of Emerging Diagnostic Technologies - Oncology Translational Medicine Integrative Sciences
Key Responsibilities:
Lead innovation in emerging diagnostic technologies (ctDNA, computational pathology, advanced imaging, multi-modal biomarker platforms) to improve patient stratification, therapeutic targeting, and mechanism-of-action insights.
Develop and apply oncology foundational models and AI/ML analytics to complex clinical/real-world/biomarker datasets (single-cell transcriptomics, spatial omics, proteomics, cfDNA).
Serve as a subject-matter expert to enable biomarker discovery and diagnostic strategies optimizing patient selection, dose determination, and combination therapy (focus on ADCs).
Oversee integration of oncology foundational models to inform translational medicine and clinical development strategies; ensure robust interpretation, implementation, and timely communication across teams.
Collaborate cross-functionally (clinical development, CPMS, Diagnostics, Translational Research, AI/ML) to apply analytics approaches for insights into complex biology.
Identify, evaluate, and implement emerging diagnostic platforms to advance innovation and pipeline growth.
Communicate analysis outputs and models to technical and non-technical stakeholders.
Champion biomarker/diagnostic strategy integration into clinical development plans.
Drive computational pathology and AI-driven image analysis; support evaluation of academic/external partnerships; contribute to business development due diligence.
Basic Qualifications:
PhD (or equivalent) in computational biology/bioinformatics/ML/computational pathology or related.
7+ years applied experience in pharma/biotech or academia (oncology research, diagnostic innovation, biomarker analysis).
Ability to lead/influence cross-functional matrix teams.
Experience with emerging diagnostic technologies in translational medicine/clinical development.
Advanced statistical/analytical methods for high-dimensional heterogeneous data.
Experience with GitHub, R Shiny/R Markdown, and cloud/HPC environments.
Preferred Qualifications:
MD with oncology clinical development experience.
Expertise in oncology foundational models and AI/ML for biomarker datasets.
Coding proficiency (R/Python) and bioinformatics tools/databases.
Experience analyzing high-dimensional datasets (single-cell/spatial transcriptomics, proteomics, cfDNA).
Computational pathology and AI image analysis; clinical trial biomarker analysis; ADC biomarker/diagnostic strategies.
Track record integrating preclinical/clinical biomarker data; familiarity with regulatory requirements/data standards.
Benefits/Compensation:
Annual bonus and eligibility for share-based long-term incentive; US base salary range: $189,750-$316,250 (for specified US locations). Health care/insurance, retirement, paid holidays/vacation, and paid caregiver/parental and medical leave.
#J-18808-Ljbffr
Worksite address
collegeville, PA, 19426, US
Who can apply
Review the original listing for work authorization, qualifications and employer requirements.